Unaudited Half Year Results for the six months ended 31 December 2017

March 30, 2018

Not for release, publication or distribution in the United States of America, the United Kingdom,The European Economic Area or Australia

 

This is a restricted communication and you must not forward it or its contents to any person to whom forwarding it is prohibited by the legends contained therein. In particular, this release and the information contained therein is not being issued and may not be distributed in the United States of America, the United Kingdom, The European Economic Area or Australia and does not constitute an offer of securities for sale in such or any other countries.Not for release, publication or distribution in the United States of America, the United Kingdom,The European Economic Area or Australia. This is a restricted communication and you must not forward it or its contents to any person to whom forwarding it is prohibited by the legends contained therein. In particular, this release and the information contained therein is not being issued and may not be distributed in the United States of America, the United Kingdom, The European Economic Area or Australia and does not constitute an offer of securities for sale in such or any other countries.

 

 

Rapid Nutrition PLC

(“Rapid Nutrition” or “the Company”)

 

Operational UpdateUnaudited Half Year Results for the six months ended 31 December 2017

 

Rapid Nutrition, a natural healthcare company focused on the research and development, manufacturing and distribution of weight-loss and diet management products, sports nutrition products, vitamins and dietary supplements and a range of life science products is pleased to announce an operational update.its Interim Results for the six months ended 31 December 2017.  

 

Excellent progress made in the period under review and the first half of the new financial year has begun strongly as the result of management actions which has transitioned the business from the licensing model to a distribution model allowing Rapid Nutrition to take greater control of its premium brands.

 

Highlights

  • Revenue reduced to £1.57m as expected (HY2016: £2.07m and FY2017: £1.92m) as a result of the strategic move from a licensing model to a distribution model

  • Gross profit margin remained similar to the previous year at 69% (HY2016: 70%)

  • Operating profit of £0.2m (HY2016: £0.6m and FY2017: £0.3m)

Outlook

  • Excellent progress made in core markets namely US, China, UK and Australia having secured leading distributors, retailers and international partnerships as well as making inroads into a well-established Chinese social media platform

  • The first half of the new financial year 2018 has begun strongly and trading is in line with the Company’s expectations

 

Simon St. Ledger, Chairman of Rapid Nutrition said: “We are pleased with the progress Rapid Nutrition has made in the period under review and the transition from a licensing model to a distribution model, with the objective of becoming vertically integrated, and our strategy to grow our distribution channels both in retails stores, online and through our e-commerce platform is well under way. The first half of the financial year has begun strongly and we are delighted to have secured a number of key retail partners. We are pursuing a number of growth opportunities to create further value and are confident of the future.

 

We are trading in line with expectations and pursuing a number of opportunities internationally to support further growth.  Rapid Nutrition has a high-quality range of wellness products together with an exciting pipeline of new product developments underway.  We are excited about the future and look forward to creating further value for our shareholders."

 

Financial Reports

 

 

Further enquires

 

Rapid Nutrition Plc      info@rnplc.com

                                    +617 3200 4222

 

About Rapid Nutrition

Rapid Nutrition is a natural healthcare company focused on the research and development, manufacturing and distribution of weight-loss and diet management products, sports nutrition products, vitamins and dietary supplements and a range of life science products. The Company has registered products in and or exported its products to Australia, Asia, India, Europe, Middle East, Africa and the US.

 

 

Legal Disclaimer:

This communication expressly or implicitly contains certain forward-looking statements concerning Rapid Nutrition PLC and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of the Rapid Nutrition group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Rapid Nutrition PLC is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

 

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange.

 

This media information is not being issued in countries where the public dissemination of the information contained herein may be restricted or prohibited by law. In particular, this media information is not being issue in the United States of America and should not be distributed to U.S. persons or publications with a general circulation in the United States. Any non-compliance with such restrictions may result in an infringement of U.S. Securities Laws. In particular, the securities of Rapid Nutrition PLC have not been registered under the U.S. Securities laws and may not be offered, sold or delivered within the United States or to U.S. persons absent the registration under or an applicable exemption from the registration requirements of the U.S. Securities laws.

 

This information is for distribution in the United Kingdom only to: persons who (i) are outside the United Kingdom; (ii) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (Order); (iii) are persons falling within Article 48(2) of the Order (certified high net worth individuals); (iv) are persons falling within Article 49(2) of the Order (high net worth companies, unincorporated associations, etc.); (v) are persons falling within article 50(1) of the Order (sophisticated investors); (vi) are persons falling within article 50A(1) of the Order (self-certified sophisticated investors); (vii) are persons falling within article 51 of the Order (associations of high net worth or sophisticated investors); or (viii) are persons to whom it may otherwise lawfully be communicated (all such persons together being Relevant Persons). This media information is only available to Relevant Persons and persons other than Relevant Persons must not act or rely on it.

 

This media information may not be provided in Australia other than to select investors ("Exempt Investors") who are able to demonstrate that they (a) fall within one or more of the categories of investors under section 708 of the Australian Corporations Act to whom an offer may be made without disclosure under Part 6D.2 of the Australian Corporations Act and (b) are "wholesale clients" for the purpose of section 761G of the Australian Corporations Act.

 

Please reload